Third Rock's Lou Tartaglia becomes full-time biotech CEO
This article was originally published in Scrip
Executive Summary
Lou Tartaglia, a former partner at Third Rock Ventures has left the venture capital company to join Solstice Biologics as president and chief executive officer. He will also join Solstice's board of directors.